THOUSAND OAKS, Calif. – THOUSAND OAKS, Calif. (AP) _ Amgen Inc. (AMGN) on Thursday reported fourth-quarter earnings of $1.8 billion.
On a per-share basis, the Thousand Oaks, California-based company said it had net income of $2.37. Earnings, adjusted for one-time gains and costs, came to $2.61 per share.
The results exceeded Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $2.27 per share.
The world’s largest biotech drugmaker posted revenue of $5.54 billion in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $5.53 billion.
Amgen expects full-year earnings in the range of $10.60 to $11 per share, with revenue in the range of $22 billion to $22.5 billion.
Amgen shares have dropped roughly 9 per cent since the beginning of the year, while the Standard & Poor’s 500 index has declined slightly more than 7 per cent. In the final minutes of trading on Thursday, shares hit $148.35, a drop of 4 per cent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMGN at http://www.zacks.com/ap/AMGN
Keywords: Amgen, Earnings Report, Priority Earnings